急性心力衰竭患者的流感疫苗接种(PANDA II):中国基于医院的平行组整群随机对照试验研究方案
PANDA II 是一项在中国县级医院开展的两臂平行组整群随机对照试验,比较出院前全面免费接种流感疫苗与常规有限使用流感疫苗对死亡或再住院主要终点的影响。连续纳入住院患者,每个秋冬流感流行期(10月至3月)每中心目标50例,连续3年达到所需样本量,出院后1、3、6、12个月集中随访。研究旨在明确流感疫苗在急性心衰患者中的有效性与安全性。
要点
- 在中国县级医院开展整群随机对照试验,比较出院前全面免费流感疫苗接种与常规有限接种。
- 主要终点为死亡或再住院,连续纳入住院患者,每个秋冬流行期每中心目标50例,连续3年。
- 出院后1、3、6、12个月集中随访,旨在明确流感疫苗在急性心衰患者中的有效性与安全性。
核心结论
- 本研究旨在明确流感疫苗接种在急性心衰住院患者中的有效性与安全性,并为未来预防策略奠定基础。
研究设计与样本
- PANDA II 为两臂平行组、基于县级医院的整群随机对照试验,比较出院前全面免费接种流感疫苗与常规有限使用流感疫苗。
- 连续纳入住院患者,每个秋冬流感流行期(10月至3月)每中心目标50例,连续3年达到所需样本量。
- 出院后1、3、6、12个月(或更早死亡)集中随访,主要终点为死亡或再住院。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Influenza vaccination confers broad benefits in the elderly and certain high-risk populations, but its effectiveness in patients with acute heart failure (HF) is uncertain. Rates of influenza vaccination are low in China due to poor awareness, cultural misunderstandings, and cost. AIMS: To determine the effectiveness of influenza vaccination in patients with acute HF admitted to hospitals in China. METHODS: The second Population Assessment of Influenza and Disease Activity (PANDA II) study is a two-arm, parallel-group, county-level hospital-based, cluster randomized controlled trial to determine the benefits and risks of full access to routine free influenza vaccination before hospital discharge, compared to routine limited use of influenza vaccination, on the primary endpoint of death or hospital readmission. Consecutive hospitalized patients at each site are enrolled to a target of 50 participants in each autumn-winter influenza outbreak period (October to March) over 3 consecutive years to reach the required sample size. Patients are centrally followed up at 1, 3, 6, and 12 months after hospital discharge (or death if earlier). Site numbers varied across year according to predicted influenza activity and logistical reasons. CONCLUSIONS: This study offers a unique chance to clarify uncertainties surrounding the effectiveness of influenza vaccination in patients with HF and to lay the groundwork for future prevention strategies. TRIAL REGISTRATION: This trial was registered with the acronym PANDA II (Population Assessment of Influenza and Disease Activity) at ChiCTR.org.cn (ChiCTR2100053264). Registered on 17 November 2021.
引用
- Zhang Y, Liu R, Zhao Y, et al. Influenza vaccination in patients with acute heart failure (PANDA II): study protocol for a hospital-based, parallel-group, cluster randomized controlled trial in China. Trials. 2024. PMID: 39587669. doi:10.1186/s13063-024-08452-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。